New FDA Approval Announced for Breyanzi

May 10, 2024
News

UPDATE: A New FDA approval has been released for Breyanzi. A request was submitted for approval for the expanded indication to include Relapsed and Refractory (R/R) Follicular Lymphoma and Marginal Zone Lymphoma with a PDUFA date of 5/23. Only the Follicular Lymphoma has been approved so far, so we are still anxiously awaiting a decision on the Marginal Zone Lymphoma with a PDUFA date of 5/23/2024 and R/R Mantle Cell Lymphoma with a PDUFA date of 5/31/2024.

An additional 3 expanded approvals on gene and cellular therapies (2 for Breyanzi and 1 for Carvykti) are expected by the end of this month!

With transformational advancements unfolding, Symphony Benefits Solution is honored to offer assistance to patients and payors in managing, supporting, coordinating, and contracting for all their Gene & Cellular therapy needs. Contact the Symphony Benefits Solution team at Sales@thesymphonyprogram.com for further information. Don’t forget to sign up for the Symphony Benefit Solutions pre-launch webinar on May 23rd at 10 a.m. CDT to discover more about this pioneering, fully integrated solution!

It is so nice to have someone fighting for me and helping me through all of this.

29 y/o Survivor Diagnosed with Ovarian Cancer

I can't say enough good things about the representative assigned to me. She was just what I needed during a difficult time and so supportive. She helped me when I was feeling down and just 'fixed things' for me. She is worth her weight in gold!!!

64 y/o Survivor Diagnosed with Breast Cancer

Since quitting smoking a few months ago, I have remained smoke-free thanks to Renalogic’s support. I receive heartfelt congratulations from Renalogic’s dedicated nurses which further motivated me on my journey. The caring nurses also encouraged me to adopt a low-sodium diet and incorporate exercise into my routine. So glad I did!

I wholeheartedly recommend Renalogic to anyone seeking a trusted partner in their health and wellness journey. Their commitment to providing invaluable resources and support is truly commendable. Thank you for helping me discover the path to a healthier, happier life.

Member

Your ability to identify and stop people from progressing to ESRD is amazing. You’ve saved us millions of dollars and helped numerous employees in their healthcare journey. We are so grateful to have a vendor like Renalogic.

Client

Struggles turn us into people we didn’t know we could be, and cancer is no different. CancerCARE saved my life when I was misdiagnosed with lymphoma weeks after my cervical cancer diagnosis. They helped me turn my struggle into grace, strength, and knowledge to fight back. And that is an empowering combination.

29 y/o Survivor Mis-diagnosed with Lymphoma

Get Updates And Stay Connected -Subscribe To Our Newsletter

Symphony Benefits Solution delivers comprehensive healthcare benefit platforms, specializing in transplant, cancer, ESRD, and gene & cell therapy, ensuring exceptional patient outcomes through cutting-edge care and expertise.

Contact Information

Recent News

Charting New Frontiers: The Impact of Gene and Cell Therapy on Healthcare

INTERLINK Premier Medical Round Table ‘Gene Therapy Has Arrived What Does the Future Hold’

Sickle Cell Gene Therapy Discussion

© 2024 Symphony Benefits Solution. All Rights Reserved.